Men generally pay less attention to their health than women do, and they are also less likely to seek out participation in clinical research, according to the Harvard Medical School. This is often a roadblock to the development of treatments for men.
ObvioHealth’s virtual study design makes it easy for men to participate in studies by speeding recruitment and facilitating ePRO. This results in higher retention rates as well as more complete and better data. See below for our experiences in conducting men’s clinical research virtually.
Assessing the Efficacy of a Dietary Supplement on Urinary Symptoms
50+ men with lower urinary tract symptoms were asked to consume the intervention over twelve weeks and record symptomatic changes via the ObvioHealth app. Efficacy was proven, with subjects reporting that the treatment had helped to relieve symptoms of LUTS.
• 3 months to fill recruitment
• 87% retention
3 Reasons Why Patients Prefer Virtual Clinical Trials
Especially when it comes to taboo topics, patients overwhelmingly prefer a virtual trial, as opposed to a site-based trial. Virtual trials help them avoid awkward face-to-face conversations with a clinician while still receiving care.Read the Article
Overactive Bladder Study
ObvioHealth is conducting an innovative study seeking FDA approval of a wearable neuromodulation device for the treatment of overactive bladder (OAB).
The ObvioHealth App
Our proprietary application brings clinical research into people’s homes, making it easier for them to participate, and easier for researchers to collect robust data sets which reflect real behaviors.
Recruitment is often a huge barrier to trial success. ObvioHealth uses digital targeting methods to find untapped populations. We identify the online behaviors that point to men with a positive pre-disposition for a specific trial and, because our studies are virtual, we are not geographically tied to a site location.
Once recruited, we enroll participants through virtual prescreening/screening and e-consent. This eliminates the burdensome cost of site retention and staffing requirements, and often shortens the recruitment period.
Men are more willing to contribute to research, knowing they can participate from the comfort and discretion of their homes without the burden of traveling to site visits. Sexual, genital and urinary health are too often viewed as taboo. Fear of uncomfortable face to face conversations can deter men from participating. Our data is most often collected through our proprietary app, giving men more privacy in their responses.
The ObvioHealth platform and app incorporates multiple data capture technologies to adapt to the needs of any given trial. These include simple survey-type completion of questionnaires and diaries, image, video and audio capture and use of wearables. Complementary data collection methods ensure more robust data based on real world outcomes.
Our platform makes it easy to trigger, track and manage products and payment of incentives. ObvioHealth can reimburse participants with the stipend program that is fully virtual. We ship any needed study supplies or devices directly to the participant’s home.
Medication Adherence & Adverse Events
An important advantage of ObvioHealth’s app is the real time remote monitoring of medication adherence and potential adverse events. Our escalating system of reminders and immediate AE/SAE detection make our studies safer while, also improving medication adherence.
Higher compliance, higher retention, more accurate data
Our easy-to-use, convenient app makes it easier for men to remain compliant. There is little to no time wasted travelling to clinical sites, so there are fewer drop-outs. All of this means that studies end on time or ahead of schedule. And because participants are able to report more real world and real time experiences, the resulting data is more accurate and reliable.